Comparison of the success rate of trabeculectomy with Oculusgen versus trabeculectomy with mitomycin C

Iranian Journal of Ophthalmology

Volumn 23, Issue 4, 2011, Pages 3-12

  Nilforushan, Naveed ^a   Yadegari, Maryam ^a   Hodjat, Parsa ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Glaucoma; Mitomycin C; Oculusgen; Trabeculectomy

Indexed keywords

EID: 80855137032     PISSN: 17354153     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996;80(5):389-93.
2. Addicks EM, Quigley HA, Green WR, Robin AL. Histologic characteristics of filtering blebs in glaucomatous eyes. Arch Ophthalmol 1983;101(5):795-8.
3. Lichter PR, Musch DC, Gillespie BW, et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 2001;108(11):1943-53.
4. Inaba Z. Long-term results of trabeculectomy in the Japanese: an analysis by life-table method. Jpn J Ophthalmol 1982;26(4):361-73.
5. Khaw PT, Tsai JC, Constable PH, et al. Preventing scarring after glaucoma filtration surgery with single application agents: a practical approach. Asia-Pacific J Ophthalmol 1995;7:6-13.
6. Lavin MJ, Wormald RP, Migdal CS, Hitchings RA. The influence of prior therapy on the success of trabeculectomy. Arch Ophthalmol 1990;108(11):1543-8.
7. Broadway D, Grierson I, Hitchings R. Adverse effects of topical antiglaucomatous medications on the conjunctiva. Br J Ophthalmol 1993;77(9):590-6.
8. Miller RD, Barber JC. Trabeculectomy in black patients. Ophthalmic Surg 1981;12(1):46-50.
9. Merritt JC. Filtering procedures in American blacks. Ophthalmic Surg 1980;11(2):91-4.
10. Beauchamp GR, Parks MM. Filtering surgery in children: barriers to success. Ophthalmology 1979;86(1):170-80.
11. Jerndal T, Lundström M. 330 trabeculectomies. A long time study (3-5 1/2 years). Acta Ophthalmol (Copenh) 1980;58(6):947-56.
12. Heuer DK, Gressel MG, Parrish RK, et al. Trabeculectomy in aphakic eyes. Ophthalmology 1984;91(9):1045-51.
13. Tomey KF, Traverso CE. The glaucomas in aphakia and pseudophakia. Surv Ophthalmol 1991;36(2):79-112.
14. Hoskins HD, Hetherington J, Shaffer RN. Surgical management of the inflammatory glaucomas. Perspect Ophthalmol 1977;1:173-81.
15. Jones NP. Glaucoma in Fuchs' Heterochromic Uveitis: aetiology, management and outcome. Eye (Lond) 1991;5 (Pt 6):662-7.
16. Allen RC, Bellows AR, Hutchinson BT, Murphy SD. Filtration surgery in the treatment of neovascular glaucoma. Ophthalmology 1982;89:1181-7.
17. Katz LJ, Spaeth GL. Surgical management of the secondary glaucomas: Part I. Ophthalmic Surg 1987;18(11):826-34.
18. Mermoud A, Salmon JF, Straker C, Murray AD. Post-traumatic angle recession glaucoma: a risk factor for bleb failure after trabeculectomy. Br J Ophthalmol 1993;77(10):631-4.
19. Watson PG, Jakeman C, Ozturk M, et al. The complications of trabeculectomy (a 20-year follow-up). Eye (Lond) 1990;4 (Pt 3):425-38.
20. Ridgway AE. Trabeculectomy. A follow-up study. Br J Ophthalmol 1974;58(7):680-6.
21. Hooi ST, Hooi SH. Trabeculectomy outcomes in a Malaysian general hospital. Med J Malaysia 2003;58(4):565-78.
22. Tan C, Chew PT, Lum WL, Chee C. Trabeculectomy--success rates in a Singapore hospital. Singapore Med J 1996;37(5):505-7.
23. Hitchings RA, Grierson I. Clinico pathological correlation in eyes with failed fistulizing surgery. Trans Ophthalmol Soc U K 1983;103 (Pt 1):84-8.
24. Chen CW, Huang HT, Bair JS, Lee CC. Trabeculectomy with simultaneous topical application of mitomycin-C in refractory glaucoma. J Ocul Pharmacol 1990;6(3):175-82.
25. Lee DA, Shapourifar-Tehrani S, Kitada S. The effect of 5-fluorouracil and cytarabine on human fibroblasts from Tenon's capsule. Invest Ophthalmol Vis Sci 1990;31(9):1848-55.
26. Lee DA, Lee TC, Cortes AE, Kitada S. Effects of mithramycin, mitomycin, daunorubicin, and bleomycin on human subconjunctival fibroblast attachment and proliferation. Invest Ophthalmol Vis Sci 1990;31(10):2136-44.
27. Stamper RL, McMenemy MG, Lieberman MF. Hypotonous maculopathy after trabeculectomy with subconjunctival 5-fluorouracil. Am J Ophthalmol 1992;114(5):544-53.
28. Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol 2003;48(3):314-46.
29. Higginbotham EJ, Stevens RK, Musch DC, et al. Bleb-related endophthalmitis after trabeculectomy with mitomycin C. Ophthalmology 1996;103(4):650-6.
30. Susanna R Jr, Takahashi W, Nicolela M. Late bleb leakage after trabeculectomy with 5-fluorouracil or mitomycin C. Can J Ophthalmol 1996;31(6):296-300.
31. Greenfield DS, Liebmann JM, Jee J, Ritch R. Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol 1998;116(4):443-7.
32. Zelefsky JR, Hsu WC, Ritch R. Biodegradable collagen matrix implant for trabeculectomy. Expert Review of Ophthalmology 2008;3(6):613-7.
33. Cairns JE. Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 1968;66(4):673-9.
34. Watson PG. Trabeculectomy: a modified ab externo technique. Ann Ophthalmol 1970;2:199-205.
35. D'Ermo F, Bonomi L, Doro D. A critical analysis of the long-term results of trabeculectomy. Am J Ophthalmol 1979;88(5):829-35.
36. Huygens M, Vercruysse K, Goethals M, Missotten L. Trabeculectomy: a retrospective long-term follow-up study. Bull Soc Belge Ophtalmol 1990;238:125-35.
37. Thommy CP, Bhar IS. Trabeculectomy in Nigerian patients with open-angle glaucoma. Br J Ophthalmol 1979;63(9):636-42.
38. Schwartz PL, Ackerman J, Beards J, et al. Further experience with trabeculectomy. Ann Ophthalmol 1976;8(2):207-17.
39. Singh K, Mehta K, Shaikh NM, et al. Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial. Ophthalmology 2000;107(12):2305-9.
40. Heuer DK, Parrish RK, Gressel MG, et al. 5-fluorouracil and glaucoma filtering surgery. II. A pilot study. Ophthalmology 1984;91(4):384-94.
41. Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of Mitomycin C. Trans Asia-Pacific Acad Ophthalmol 1983;9:172-7.
42. Kitazawa Y, Kawase K, Matsushita H, Minobe M. Trabeculectomy with mitomycin. A comparative study with fluorouracil. Arch Ophthalmol 1991;109(12):1693-8.
43. Skuta GL, Beeson CC, Higginbotham EJ, et al. Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery. Ophthalmology 1992;99(3):438-44.
44. Smith MF, Sherwood MB, Doyle JW, Khaw PT. Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma. Am J Ophthalmol 1992;114(6):737-41.
45. Egbert PR, Williams AS, Singh K, et al. A prospective trial of intraoperative fluorouracil during trabeculectomy in a black population. Am J Ophthalmol 1993;116(5):612-6.
46. Singh K, Egbert PR, Byrd S, et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol 1997;123(1):48-53.
47. Tham CC, Lai JS, Poon AS, et al. Results of trabeculectomy with adjunctive intraoperative mitomycin C in Chinese patients with glaucoma. Ophthalmic Surg Lasers Imaging 2006;37(1):33-41.
48. Fontana H, Nouri-Mahdavi K, Lumba J, et al. Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology 2006;113(6):930-6.
49. Adenis JP, Duprat F. 5-Fluorouracil and trabeculectomy. A trial of low doses. J Fr Ophthalmol 1990;13(4):169-75.
50. Nakano Y, Araie M, Shirato S. Effect of postoperative subconjunctival 5-fluorouracil injections on the surgical outcome of trabeculectomy in the Japanese. Graefes Arch Clin Exp Ophthalmol 1989;227(6):569-74.
51. Watanabe J, Iwata K, Sawaguchi S, Nanba K. Trabeculectomy with 5-fluorouracil. Acta Ophthalmol (Copenh) 1991;69(4):455-61.
52. Katz GJ, Higginbotham EJ, Lichter PR, et al. Mitomycin C versus 5-fluorouracil in high-risk glaucoma filtering surgery. Extended follow-up. Ophthalmology 1995;102(9):1263-9.
53. Hong SJ, Wu KY, Wang HZ, Lai YH. Toxic effects of mitomycin-C on cultured ciliary process cells and trabecular meshwork cells. J Ocul Pharmacol Ther 2001;17(4):331-42.
54. Mietz H, Roters S, Krieglstein GK. Bullous keratopathy as a complication of trabeculectomy with mitomycin C. Graefes Arch Clin Exp Ophthalmol 2005;243(12):1284-7.
55. Sauder G, Jonas JB. Limbal stem cell deficiency after subconjunctival mitomycin C injection for trabeculectomy. Am J Ophthalmol 2006;141(6):1129-30.
56. Beatty S, Potamitis T, Kheterpal S, O'Neill EC. Trabeculectomy augmented with mitomycin C application under the scleral flap. Br J Ophthalmol 1998;82(4):397-403.
57. Lim LA, Chindasub P, Kitnarong N. The surgical outcome of primary trabeculectomy with mitomycin C and A fornix-based conjunctival flap technique in Thailand. J Med Assoc Thai 2008;91(10):1551-7.
58. Chen HS, Ritch R, Krupin T, Hsu WC. Control of filtering bleb structure through tissue bioengineering: An animal model. Invest Ophthalmol Vis Sci 2006;47(12):5310-4.
59. Papaconstantinou D, Georgalas I, Karmiris E, et al. Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol 2010;88(1):80-5.
60. Rosentreter A, Schild AM, Jordan JF, et al. A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye (Lond) 2010;24(9):1449-57.
61. Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression, results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120(10):1268-79.